This program aims to provide pharmacists with an overview and literature supporting treatment of liver injury and disease, including drug-induced liver injury (DILI), alcohol-related liver disease, non-alcoholic fatty liver disease (NAFLD).
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose.
- Discuss causes of liver injury and disease
- Evaluate evidence behind treatment methods
- Apply evidence to patient scenarios
Carrie Hansen, PharmD
Release Date: May 20, 2020
Credit Expiration Date: May 20, 2023